Pharmaceutical applications of zeta potential - Interest for colloidal drug carriers characterization;Applications pharmaceutiques du potentiel zeta - Interet pour la caracterisation des vecteurs colloidaux

Journal de Pharmacie de Belgique

Volumn 55, Issue 2, 2000, Pages 40-48

  Boehm, Anne Laure Le Roy ^a   Fessi, Hatem ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; DRUG VEHICLE; LIPOSOME; NANOPARTICLE;

COLLOID; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG TARGETING; ENCAPSULATION; LIPOPHILICITY; MICROEMULSION; PHYSICAL CHEMISTRY; REVIEW; SURFACE PROPERTY; ZETA POTENTIAL;

EID: 6744237782     PISSN: 00472166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. JANI P., HALBERT G.W., LANGRIDGE J., FLORENCE A.T. - Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependancy. J. Pharm. Pharmacol., 1990, 42, 821-826
2. ILLUM L., KHAN M.A., MARK E., DAVIS S.S. - Evaluation of carrier capacity and release characteristics for poly (butyl-2-cyanoacrylate) nanoparticles. Int. J. Pharm., 1986, 30, 17-28
3. ABRAHAM I., GOUNDALKAR A., MEZET M. - Effect of liposomal surface charge on the pharmacokinetics of an encapsulated model compound. Biopharm. Drug Dispos., 1984, 5, 387-398
4. SENIOR J. - Fate and behaviour of liposomes in vivo : a review of controlling factors. CRC Critical Review in Therapeutic Drug Carrier System, 1987, 3, 123-193
5. ROLLAND A. - Pharmaceutical particulate earriers. Therapeutic Application. Ed MDl Dekker, 1993
6. DAVIS S.S., McVIE J.G., TOMLINSON E. - Microspheres and drug therapy, pharmaceutical, immunological and medical aspects (Elsevier), 1984, pp. 25-37
7. MÜLLER R.H. - Colloïdal carriers for controlled drug delivery and targeting, Wissenschaftliche Verlaggesellshaft, Stuttgart, and CRC Press, Boca Raton, Florida, 1991
8. COUVREUR P., DUBERNET C., PUISIEUX F. - Controlled drug delivery with nanoparticles : Current possibilities and future trends. Eur. J, Pharm. Biopharm., 1995, 41, 2-13
9. PUISIEUX F. - Vecteurs micro et nanoparticulaires, les liposomes edited by Buri P., Puisieux F. Doelker E. Benoit J.P., Formes pharmaceutiques nouvelles aspects technologiques biopharmaceutiques et médicaux. Lavoisier Tec et Doc, 1985
10. MAHANTY J., NINHAM B.W. - Dispersion forces, Academic Press, New York, 1976
11. LONDON F. - Zur theorie und systemik der molekularkrafte. Z. Physik, 1930, 63, 245-279
12. DERJAGUIN B., LANDAU L.D. - Theory of the stability of strongly lyophobic sols and the adhesion of strongly changed particles in solutions of electrolytes. Acta Physicochim., 1941, 14, 633-662
13. VERWEY E.J.W., OVERBEEK J. TH. G. - Theory of the stability of lyophobic colloids, Elsevier, Amsterdam, 1948
14. ISRAELACHVILI J.N. - Intermolecular and surface forces. Second Edition, Academic Press. London, 1991
15. NAPPER D. - Polymeric stabilization of colloïdal dispersions. Academic Press, Orlando, 1983
16. HOUGH D.B., THOMPSON L. - Effect of non ionic surfactants on the stability of dispersions. In : Non ionic surfactants. Physical Chemistry, edited by M.J. Schick, pp. 601-676. Marcel Dekker, New York, 1987
17. DANIEL J.C., AUDEBERT R. - Petits volumes et grandes surfaces : Univers des colloïdes. In : La Juste Argile, edited by M. Daoud et al, pp. 85-133. Les Editions de Physique, Les Ulis. 1995
18. GOUY M. - Sur la constitution de la charge électrique àla surface d'un électrolyte. J. Phys., 1910, 9, 457-468
19. STERN O. - Zur theorie der elektrischen doppelschicht. Z. Elektrochem., 1924, 30, 508-516
20. GRAHAME D.C. - The electrical double layer and the theory of electrocapillarity. Chem. Rev., 1947, 41, 441-501
21. HUNTER R.J. - Zeta potential in colloïd sciences, Academic Press, London, 1981
22. MALVERN - Guide pratique d'utilisation du potentiel zeta : étude de la stabilité des émulsions et suspensions, 1997
23. FLORENCE A.T., ATTWOOD D. - Physicochemical principles of pharmacy, MacMillan Press, London, 2nd ed., 1988, pp. 229-278
24. LABHASETWAR V., DORLE A.K. - A study on the zeta potential of microcapsules during ageing. J. Microencapsul., 1991, 8 (1), 83-85
25. REICH G. - In vitro stability of poly(d,l-lactide) and poly(d, l-lactide) / poloxamer nanoparticles in gastro-intestinal fluids. Drug Dev. Ind. Pharm., 1997, 23 (12), 1191-1200
26. FREITAS C. , MÜLLER R.H. - Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLN) dispersions. Int. J. Pharm., 1998, 168, 221-229
27. LABHASETWAR V., MOHAN M.S., DORLE A.K. - A study on zeta potential and dielectric constant of liposomes. J. Microencapsul., 1994, 11 (6), 663-668
28. LIN W., COOMBES A.G.A., GARNETT M.C., DAVIES M.C., SCHACHT E., DAVIS S.S., ILLUM L. - Preparation of sterically stabilized human serum albumin nanospheres using a novel dextranox MEPG crosslinking agent. Pharm. Res., 1994, 11 (11), 1588-1592
29. DE PLESSIS J., RAMACHANDRAN C., WEINER N., MULLER D.G. - The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int. J. Pharm., 1996, 127, 273-278
30. BENITA S., POLY P.A., PUISIEUX F., DELATTRE J. - Radiopaque liposomes : Effects of formulation conditions on encapsulation efficiency. J. Pharm. Sci., 1984, 73 (12), 1751-1754
31. LAWRENCE S.M., ALPAR H.O., MCALLISTER S.M., BROWN R.W. Liposomal (MLV) polymixin B : Physicochemical characterization and effect of surface charge on drug association. J. Drug Target., 1993, 1, 303-310
32. DE CHASTEIGNER S., FESSI H., DEVISSAGUET J.P., PUISIEUX F. - Comparative study association of itraconazole with colloidal drug carriers. Drug Dev. Res., 1996, 38, 125-133
33. LOSA C., MARCHAL HEUSSLER L., ORALLOF., VILAJATO L., ALONSO M.J. - Design of a new formulation for topical ocular administration polymeric nanocapsules containing metoprolol, Pharm. Res., 1993, 10, 80-87
34. PERACCHIA M.T., VAUTHIER C., DESMAËLE D., GULIKA., DEDIEU J.C., DEMOY M., D'ANGELO J., COUVREUR P. - Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate hexadecyl cyanoacrylate amphiphilic copolymer. Pharm. Res., 1998, 15 (4), 550-556
35. MÜLLER R.H., LHERM C., HERBORT J., BLUNK T., COUVREUR P. - Alkylcyanoacrylate drug carriers : 1. Physicochemical characterization of nanoparticles with different alkyl chain lenght. Int. J. Pharm., 1992, 84, 1-11
36. TOBIO M., GREF R., SANCHEZ A., UNGER R., ALONSO M.J. - Stealth PLAPEG nanoparticles as protein carriers for nasal administration. Pharm. Res., 1998, 15 (2), 270-275
37. PRIVITERA N., NAON R., RIESS J.G. - Phagocytosis by cultured mouse peritoneal macrophages of microspheres cated with perfluorialkylated telomeric surfactants derived from tris (hydroxymethyl)aminomethane. Int. J. Pharm., 1994, 104, 41-48
38. WILKINS D.J., MYERS P.A. - Studies on the relationship between the electrophoretic properties of colloids and their blood clearance and organ distribution in the rat. Brit. J. Exp. Path., 1966, 47, 568-576
39. JULIANO R.L., STAMP D. - The effect of particle size and charge on the clearence of liposomes encapsulated drugs. Biochem. Biophys. Research Comm., 1975, 63, 651-658
40. TAN L., GREGORlADIS G. - Pharmacokinetic behaviour of charged liposomes in vivo and the influence of charge, lipid composition and pH on electrophoretic mobility in vitro. Asia Pac. J. Pharmacol., 1990, 5, 297-303
41. KIM C.K., HAN J.H. - Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. J. Microencapsul., 1995, 12 (4), 437-446
42. TRȮSTER S.D., KREUTER J. - Contact angles of surfactants with a potential to alter the body distribution of colloidal drug carriers on poly(methyl-methacrymate surfaces. Int. J. Pharm., 1988, 45, 91-100
43. ILLUM L., DAVIS S.S. - The organ uptake of intravenously administerd colloidal particles can be altered usinga non ionic surfactant (poloxamer 338). FEBS Letters, 1984, 67, 79-82
44. MŪLLER R.H., WALLIS K.H., TRŌSTER S.D., KREUTER J. - In vitro characterization of poly (methyl-methacrylate) nanoparticles and correlation to their in vivo fate. J. Control. Release, 1992, 20, 237-246
45. LŪCK M., PAULKE B.R., SCHRȮDER W, BLUNK T., MŪLLER R.H. - Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characte-ristics. J. Biomed. Mater. Res., 1998, 39, 478-485
46. LACASSE F.X., FILION M.C., PHILLIPS N.C, ESCHER E., MC MULLEN J.N., HILDGEN P. - Influence of surface properties at biodegradable microsphere surfaces : Effects on plasma protein adsorption and phagocy-tosis. Pharm. Res., 1998, 15 (2), 312-317
47. CHOULY C., POULIQUEN D., LUCET I., JEUNE J.J., JALLET P. - Development of superparamagnetic nanoparticles for MRl : effect of particle size, charge and surface nature on biodistribution. J. Microencapsul., 1996, 13 (3), 245-255
48. TABATA Y., IKEDA Y. - Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials, 1988, 9, 356-362
49. KISSEL T., ROSER M. - Influence of chemical surface modification on the phagocytic properties of albumin nanoparticles. Proceed Intern. Control. Rel. Bioactiv. Mater, 1991, 18, 275-276
50. SCHWENDENER R.A., CAGOCKI P.A., RAHMAN Y.E. - The effect of charge and size in the interaction of unilamellar liposomes with macrophage. Biochim. Biophys. Acta, 1984, 722, 93-101
51. PRIVITERA N., NAON R., VIERLING P., RIESS J.G. - Phagocytic uptake by mouse peritoneal macrophages of microspheres coated with phosphocholine or polyethylene glycol phosphate derived perfluoroalkylated surfactants. Int J. Pharm., 1995, 120, 73-82
52. HAWLEY A.E., ILLUM L., DAVIS S.S. - Preparation of biodegradable, surface engineered PLGA nanospheres with enhancemed lymphatic drainage and lymph node uptake. Pharm. Res., 1997, 14(5), 657-661
53. NEAL J.C., STOLNIK S., GARNETT M.C., DAVIS S.S, ILLUM L. - Modification of the copolymers poloxamer 407 and poloxamme 908 can affect lhe physical and biological properties of surface modified nanopsheres. Pharm. Res., 1998, 15 (2),